A coding error in several Microsoft 365 Android apps could have allowed a malicious app on the same device to silently obtain account tokens and act as the signed-in user, according to new research ...

Cybersecurity researchers have disclosed details of a new malicious supply chain campaign that's targeting developers using OpenAI Codex through a legitimate-looking remote web UI. The tool, named ...

AI is turning out to be more expensive than enterprises expected, and CFOs are now trading future headcount for tokens. Roughly 95% of enterprise AI still runs on the priciest frontier models even for ...

When it comes to AI, tokens are the coin of the realm. Here’s how to understand their importance to both users and AI vendors. Google has only one way to measure the phenomenal AI growth it’s seen: in ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Peter Steinberger is on a token spending spree. On Friday, the creator of OpenClaw posted a screenshot ...

Some time earlier this year, an employee at tech giant Meta built a system to track how much each staff member was using artificial intelligence (AI). Named “Claudeonomics” after the Claude chatbot, ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Signange of AI (Artificial Intelligence) is displayed during the MWC (Mobile World Congress) ...

Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...

Eli Lilly LLY-1.93%decrease; red down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...

China’s cheap artificial intelligence models are rapidly attracting global users and creating new winners in the nation’s stock market. As AI development increasingly focuses on performing a diverse ...